TrialNeuro-oncology2014

A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).

Markus Hutterer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.